Paper
Fenugreek: A therapeutic complement for patients with borderline hyperlipidemia: A randomised, double-blind, placebo-controlled, clinical trial
Published Apr 1, 2017 · E. Yousefi, S. Zareiy, R. Zavoshy
Advances in integrative medicine
21
Citations
1
Influential Citations
Abstract
Abstract removed due to Elsevier request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
Study Snapshot
Key takeawayFenugreek seeds supplementation can effectively reduce triglycerides, total cholesterol, LDL, and fasting blood glucose in patients with borderline hyperlipidemia.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.
Full text analysis coming soon...
References
···
···
···
···
Citations
···
···
···
···